Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scott

Showing results (271-280 of 355) with videos related to

Pageof 36
Sort By:
Cancer Discovery|August 20, 2013
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphomaThomas Clozel, ShaoNing Yang, Rebecca L Elstrom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study GroupAnnette M Staiger, Marita Ziepert, Heike Horn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue BiopsiesDavid W Scott, Anja Mottok, Daisuke Ennishi, et al.
Blood|March 30, 2017
Genetic profiling of <i>MYC</i> and <i>BCL2</i> in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impactDaisuke Ennishi, Anja Mottok, Susana Ben-Neriah, et al.
Cancer Cell|April 9, 2024
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesisDarko Barisic, Christopher R Chin, Cem Meydan, et al.
Blood Advances|September 18, 2025
Development and validation of a gene expression signature to predict early events in patients with follicular lymphomaColleen A Ramsower, George Wright, Hongli Li, et al.
Cancer Cell|March 8, 2024
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesisDarko Barisic, Christopher R Chin, Cem Meydan, et al.
Blood Cancer Journal|October 7, 2024
MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt LymphomaSara Mato, Natalia Castrejón-de-Anta, Ariadna Colmenero, et al.
Blood|November 15, 2014
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroupFong Chun Chan, Adele Telenius, Shannon Healy, et al.
Blood|April 21, 2023
Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patternsKostiantyn Dreval, Laura K Hilton, Manuela Cruz, et al.
Pageof 36

Showing results (271-280 of 355) with videos related to

Sort By:
Pageof 36
Cancer Discovery|August 20, 2013
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphomaThomas Clozel, ShaoNing Yang, Rebecca L Elstrom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study GroupAnnette M Staiger, Marita Ziepert, Heike Horn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue BiopsiesDavid W Scott, Anja Mottok, Daisuke Ennishi, et al.
Blood|March 30, 2017
Genetic profiling of <i>MYC</i> and <i>BCL2</i> in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impactDaisuke Ennishi, Anja Mottok, Susana Ben-Neriah, et al.
Cancer Cell|April 9, 2024
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesisDarko Barisic, Christopher R Chin, Cem Meydan, et al.
Blood Advances|September 18, 2025
Development and validation of a gene expression signature to predict early events in patients with follicular lymphomaColleen A Ramsower, George Wright, Hongli Li, et al.
Cancer Cell|March 8, 2024
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesisDarko Barisic, Christopher R Chin, Cem Meydan, et al.
Blood Cancer Journal|October 7, 2024
MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt LymphomaSara Mato, Natalia Castrejón-de-Anta, Ariadna Colmenero, et al.
Blood|November 15, 2014
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroupFong Chun Chan, Adele Telenius, Shannon Healy, et al.
Blood|April 21, 2023
Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patternsKostiantyn Dreval, Laura K Hilton, Manuela Cruz, et al.
Pageof 36